President Donald Trump announced that his administration would tackle rising drug costs in the United States by establishing “most favored nation” pricing which would base the U.S. prices of pharmaceuticals on the lowest prices paid by other foreign nations.

NIH Director Dr. Jay Bhattacharya reacted to President Donald Trump's executive order on Monday targeting drug prices, where he announced the government "will no longer tolerate profiteering and price gouging from Big Pharma.